Barclays’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-25,865
Closed -$1.37K 4816
2023
Q2
$1.37K Sell
25,865
-11,237
-30% -$7.11K ﹤0.01% 4344
2023
Q1
$44.5K Buy
37,102
+17,240
+87% +$38.4K ﹤0.01% 4480
2022
Q4
$28.2K Sell
19,862
-9,588
-33% -$20.6K ﹤0.01% 4742
2022
Q3
$72K Buy
29,450
+6,358
+28% +$21.2K ﹤0.01% 3662
2022
Q2
$53K Sell
23,092
-35,325
-60% -$132K ﹤0.01% 4018
2022
Q1
$393K Sell
58,417
-66,344
-53% -$567K ﹤0.01% 3049
2021
Q4
$1.13M Buy
124,761
+39,938
+47% +$371K ﹤0.01% 2751
2021
Q3
$857K Buy
84,823
+16,042
+23% +$176K ﹤0.01% 2870
2021
Q2
$883K Sell
68,781
-49,168
-42% -$674K ﹤0.01% 2736
2021
Q1
$1.67M Sell
117,949
-72,962
-38% -$1M ﹤0.01% 2449
2020
Q4
$2.04M Buy
190,911
+5,004
+3% +$45.5K ﹤0.01% 2223
2020
Q3
$1.42M Sell
185,907
-16,248
-8% -$119K ﹤0.01% 2393
2020
Q2
$1.23M Sell
202,155
-48,698
-19% -$240K ﹤0.01% 2573
2020
Q1
$884K Buy
250,853
+133,843
+114% +$1.13M ﹤0.01% 3086
2019
Q4
$1.24M Sell
117,010
-319,786
-73% -$2.84M ﹤0.01% 3482
2019
Q3
$4.89M Buy
436,796
+183,718
+73% +$2.18M ﹤0.01% 1874
2019
Q2
$2.32M Buy
253,078
+105,168
+71% +$1.1M ﹤0.01% 2729
2019
Q1
$1.64M Buy
147,910
+115,767
+360% +$809K ﹤0.01% 2799
2018
Q4
$81K Sell
32,143
-67,475
-68% -$242K ﹤0.01% 5194
2018
Q3
$449K Buy
99,618
+61,715
+163% +$450K ﹤0.01% 4365
2018
Q2
$454K Sell
37,903
-32,636
-46% -$437K ﹤0.01% 4039
2018
Q1
$1.09M Buy
70,539
+39,465
+127% +$659K ﹤0.01% 3106
2017
Q4
$508K Buy
31,074
+28,324
+1,030% +$548K ﹤0.01% 3817
2017
Q3
$63K Buy
2,750
+2,288
+495% +$48.7K ﹤0.01% 5218
2017
Q2
$14K Sell
462
-2,407
-84% -$66.6K ﹤0.01% 5944
2017
Q1
$88K Sell
2,869
-7,467
-72% -$211K ﹤0.01% 4976
2016
Q4
$260K Buy
10,336
+7,509
+266% +$177K ﹤0.01% 3987
2016
Q3
$70K Sell
2,827
-854
-23% -$22.7K ﹤0.01% 4769
2016
Q2
$92K Sell
3,681
-8,622
-70% -$222K ﹤0.01% 4462
2016
Q1
$345K Buy
12,303
+6,515
+113% +$170K ﹤0.01% 3436
2015
Q4
$174K Buy
5,788
+3,969
+218% +$135K ﹤0.01% 4016
2015
Q3
$53K Sell
1,819
-3,706
-67% -$120K ﹤0.01% 4994
2015
Q2
$193K Sell
5,525
-40,233
-88% -$1.42M ﹤0.01% 4169
2015
Q1
$1.6M Sell
45,758
-2,741
-6% -$92.4K ﹤0.01% 2522
2014
Q4
$1.65M Sell
48,499
-5,431
-10% -$192K ﹤0.01% 2700
2014
Q3
$1.89M Sell
53,930
-2,381
-4% -$89.8K ﹤0.01% 2716
2014
Q2
$2.25M Sell
56,311
-7,156
-11% -$275K ﹤0.01% 2470
2014
Q1
$2.48M Buy
63,467
+18,386
+41% +$662K ﹤0.01% 2346
2013
Q4
$1.49M Sell
45,081
-5,303
-11% -$165K ﹤0.01% 2961
2013
Q3
$1.46M Buy
50,384
+10,051
+25% +$315K ﹤0.01% 2933
2013
Q2
$1.36M Buy
+40,333
New +$1.25M ﹤0.01% 2983

Barclays's DBD Position: Q3 2023 in Review

Barclays sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2023, closing a stake of 25,865 shares — an estimated $1.37K sold.

Barclays first reported a position in DBD in Q2 2013 and held it in 41 quarters. The position peaked at $4.89M in Q3 2019. 0 funds tracked by Wall St. Rank hold DBD as of Q3 2023.

  • Barclays reported no remaining Diebold Nixdorf Incorporated position as of Q3 2023 after selling out during the quarter.
  • Barclays sold 25,865 Diebold Nixdorf Incorporated shares in Q3 2023, an estimated $1.37K.
  • Barclays first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 41 quarters.
  • Barclays's Diebold Nixdorf Incorporated position peaked at $4.89M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2023.

Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.